Monte Carlo evaluation of out-of-field dose in 18 MV pelvic radiotherapy using a simplified female MIRD phantom
暂无分享,去创建一个
N. Mohammadi | Z. Alirezaei | G. Geraily | H. Vega-Carrillo | I. Jabbari | S. Elmtalab | S. Martinez-Ovalle | A. Karimi
[1] I. Abedi,et al. Investigating the out-of-field doses and estimating the risk of secondary thyroid cancer in high-grade gliomas radiation therapy with modulated intensity and 3D-conformal: a phantom study , 2021, International Journal of Radiation Research.
[2] P. Tangboonduangjit,et al. Secondary cancer risk from modern external-beam radiotherapy of prostate cancer patients: Impact of fractionation and dose distribution , 2021, Journal of radiation research.
[3] R. Khabaz. Phantom dosimetry and cancer risks estimation undergoing 6 MV photon beam by an Elekta SL-25 linac. , 2020, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[4] B. Sánchez-Nieto,et al. Study of out‐of‐field dose in photon radiotherapy: A commercial treatment planning system versus measurements and Monte Carlo simulations , 2020, Medical physics.
[5] A. H. Karimi,et al. Grid therapy vs. conventional radiotherapy - 18 MV treatments: Photoneutron contamination along the maze of a linac bunker. , 2020, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[6] Hosein Ghiasi,et al. Monte Carlo study on the secondary cancer risk estimations for patients undergoing prostate radiotherapy: A humanoid phantom study. , 2020, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.
[7] M. Najafi,et al. Different Methods of Measuring Neutron Dose/Fluence Generated During Radiation Therapy with Megavoltage Beams , 2020, Health physics.
[8] H. Brkić,et al. Essential considerations for accurate evaluation of photoneutron contamination in Radiotherapy. , 2019, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[9] A. H. Karimi,et al. Photoneutron Dose Estimation in GRID Therapy Using an Anthropomorphic Phantom: A Monte Carlo Study , 2018, Journal of medical signals and sensors.
[10] M. Benam,et al. Estimation of photoneutron dosimetric characteristics in tissues/organs using an improved simple model of linac head. , 2018, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[11] Ryan L. Smith,et al. Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis. , 2014, International journal of radiation oncology, biology, physics.
[12] A. Lallena,et al. Neutron dose equivalent and neutron spectra in tissue for clinical linacs operating at 15, 18 and 20 MV. , 2011, Radiation protection dosimetry.
[13] Wesley E Bolch,et al. REVISIONS TO THE ORNL SERIES OF ADULT AND PEDIATRIC COMPUTATIONAL PHANTOMS FOR USE WITH THE MIRD SCHEMA , 2006, Health physics.
[14] Gary D Fullerton,et al. Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies. , 2006, Medical physics.
[15] David S Followill,et al. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy. , 2005, International journal of radiation oncology, biology, physics.
[16] J. Neglia,et al. Hypersensitivity and idiosyncratic reactions to oxaliplatin , 2004, Cancer.
[17] D. Brenner,et al. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery , 2000, Cancer.
[18] D. Schultz,et al. Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] K. Kase,et al. Higher energy: is it necessary, is it worth the cost for radiation oncology? , 1992, Medical physics.
[20] R. Taylor,et al. Dose levels outside radiotherapy beams. , 1983, The British journal of radiology.
[21] J. Purdy,et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications , 1984, Cancer.
[22] K. Kase,et al. Measurements of dose from secondary radiation outside a treatment field. , 1983, International journal of radiation oncology, biology, physics.